Multiple endocrine neoplasias: Advances and challenges for the future

Journal of Internal Medicine

Volumn 266, Issue 1, 2009, Pages 1-4

  Alevizaki, M ^a   Stratakis, C A ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Genetics; Multiple neoplasia syndromes; Oncogenes; Tumour suppressor genes

Indexed keywords

ARYL HYDROCARBON RECEPTOR BINDING PROTEIN; BINDING PROTEIN; CYCLIC AMP; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PHOSPHODIESTERASE; PHOSPHODIESTERASE 11A; PHOSPHODIESTERASE 8B; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE C; SUCCINATE DEHYDROGENASE D; UNCLASSIFIED DRUG;

ADRENAL TUMOR; CARCINOGENESIS; CARNEY COMPLEX; CARNEY STRATAKIS SYNDROME; CONFERENCE PAPER; CUSHING SYNDROME; GENE ACTIVATION; GENE MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENOME ANALYSIS; HUMAN; HYPOPHYSIS TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE RET; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA;

CELL TRANSFORMATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA;

EID: 66849087634     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02108.x     Document Type: Conference Paper

References (26)

1. Brandi ML, Gagel RF, Angeli A et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86: 5658-71.
2. Marx SJ, Simonds WF. Hereditary hormone excess: genes, molecular pathways, and syndromes. Endocr Rev 2005; 26: 615-61.
3. Ribeiro RC, Rodriguez-Galindo C, Zambetti GP et al. Uncommon endocrine tumors in children and adolescents. Section 11: Pediatric Malignancies. In: Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG, Mayer IA (Assoc. Editor), eds. Textbook of Uncommon Cancers, 3rd edn. chapter 70. Hoboken, NJ, USA: John Wiley & Sons, Ltd, 2006; 775-97.
4. Stratakis CA, Marx SJ. Multiple endocrine neoplasias in the era of translational medicine. Horm Metab Res 2005; 37: 343-6.
5. Marx SJ, Stratakis CA. Multiple endocrine neoplasia - an introduction. J Intern Med 2005; 257: 2-5.
6. Vierimaa O, Georgitsi M, Lehtonen R et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006; 312: 1228-30.
7. Horvath A, Boikos S, Giatzakis C et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 2006; 38: 794-800.
8. Horvath A, Mericq V, Stratakis CA. Mutation in PDE8B, a cAMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med 2008; 358: 750-2.
9. Pellegata NS, Quintanilla-Martinez L, Siggelkow H et al. Germline mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 2006; 103: 15558-63.
10. Tichomirowa MA, Daly AF, Beckers A. Familial pituitary adenomas. J Intern Med 2009; 266: 5-18.
11. Georgitsi M, Raitila A, Karhu A et al. Germline CDKN1B ? p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 2007; 92: 3321-5.
12. McWhinney SR, Pasini B & Stratakis CA from the Carney Triad & Carney-Stratakis Dyad ? Syndrome Consortium. Mutations of the genes coding for the succinate dehydrogenase subunit genes in familial gastrointestinal tumors. N Engl J Med 2007; 357: 1054-6.
13. Pasini B, McWhinney SR, Bei T et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 2008; 16: 79-88.
14. Pasini B, Stratakis CA. SDH mutations in tumourigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 2009; 266: 19-42.
15. Matyakhina L, Bei TA, McWhinney SR et al. Genetics of Carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab 2007; 92: 2938-43.
16. Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumors, and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis Syndrome): molecular genetics and clinical implications. J Intern Med 2009; 266: 43-52.
17. Calender A, Vercherat C, Gaudray P, Chayvialle JA. GENEM (Groupe d' Etude des Neoplasies Endocriniennes Multiples). Deregulation of genetic pathways in neuroendocrine tumors. Ann Oncol 2001; 12(Suppl 2): S3-11.
18. Neumann HP, Bausch B, McWhinney SR et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346: 1459-66.
19. Horvath A, Giatzakis C, Robinson-White A et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res 2006; 66: 11571-5.
20. Dreijerink KMA, Lips CJM, Timmers HThM. Multiple endocrine neoplasia type 1: a chromatin writer's block. J Intern Med 2009; 266: 53-59.
21. Kirschner LS. Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex. J Intern Med 2009; 266: 60-68.
22. Falchetti A, Marini F, Giusti F, Cavalli L, Cavalli T, Brandi ML. DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes. J Intern Med 2009; 266: 69-83.
23. Newey PJ, Bowl MR, Thakker RV. Parafibromin - functional insights. J Intern Med 2009; 266: 84-98.
24. Santarpia L, Ye L, Gagel RF. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma. J Intern Med 2009; 266: 99-113.
25. Machens A, Lorenz K, Dralle H. Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities. J Intern Med 2009; 266: 114-125.
26. van Veelen W, de Groot JWB, Acton DS et al. Medullary thyroid carcinoma and biomarkers: past, present and future. J Intern Med 2009; 266: 126-140.